The United States is short hundreds of thousands of physicians by most projections, and the shortage is routinely framed as a mysterious labor problem. It isn’t mysterious. The pipeline that produces doctors has been throttled at multiple points for decades — by accreditation bodies, by Medicare-funded residency caps, and by professional incentives to keep entry narrow. The shortage is a policy outcome, not a market failure.
Residency slots, not med school seats, are the real bottleneck
Medical schools have actually expanded enrollment over the past two decades. The chokepoint sits one stage downstream: residency. Most US residency positions are funded by Medicare, and Congress capped that funding in the 1997 Balanced Budget Act. The cap has been adjusted only modestly since. That means even when more medical graduates enter the pipeline, there aren’t enough training slots to turn them into practicing physicians. Every year, qualified MDs go unmatched and effectively can’t practice. The shortage is manufactured downstream of admissions.
Accreditation gatekeeping limits new schools
Opening a new medical school requires navigating the Liaison Committee on Medical Education, a process that takes years and substantial capital. The accreditation framework was designed to maintain quality after the Flexner Report a century ago, but it has hardened into a barrier that protects incumbents. Comparable countries have expanded medical training capacity faster by allowing more institutions to qualify. The US system makes new schools rare and expensive to launch, which keeps overall capacity tight even as the population grows and ages.
The economics reward scarcity
Physician scarcity supports physician compensation, and the professional bodies most influential over training capacity are dominated by physicians. This is not a conspiracy — it’s a predictable outcome when an industry self-regulates entry. The American Medical Association historically opposed expansion of medical school slots in the 1980s and 1990s, citing oversupply concerns that turned out to be wrong. Loosening those constraints would increase access and probably compress specialist incomes. The political will to do that has been weak in Washington for thirty years.
International graduates and NPs fill the gap imperfectly
The system has compensated by leaning on internationally trained physicians (about a quarter of US doctors graduated abroad) and by expanding the scope of nurse practitioners and physician assistants. Both adaptations help, but neither fully substitutes for trained physicians, particularly in specialties. Foreign-trained doctors face a brutal relicensing path that wastes years of expertise. The mid-level expansion is uneven across states. The cleanest fix — uncapping residency slots and easing new school accreditation — keeps getting deferred.
The bottom line
The US doctor shortage is a foreseeable result of policies that limit how many physicians can be trained. Residency caps set in 1997, slow accreditation of new schools, and professional incentives to maintain scarcity all combine to keep the supply tight while demand climbs. Calling it a workforce mystery misses the design. The bottleneck is identifiable, the levers are known, and the reason they haven’t been pulled is political, not practical.
Leave a Reply